Literature DB >> 10359843

Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.

K Sjögren1, J L Liu, K Blad, S Skrtic, O Vidal, V Wallenius, D LeRoith, J Törnell, O G Isaksson, J O Jansson, C Ohlsson.   

Abstract

The body growth of animals is regulated by growth hormone and IGF-I. The classical theory of this regulation is that most IGF-I in the blood originates in the liver and that body growth is controlled by the concentration of IGF-I in the blood. We have abolished IGF-I production in the livers of mice by using the Cre/loxP recombination system. These mice demonstrated complete inactivation of the IGF-I gene in the hepatocytes. Although the liver accounts for less than 5% of body mass, the concentration of IGF-I in the serum was reduced by 75%. This finding confirms that the liver is the principal source of IGF-I in the blood. However, the reduction in serum IGF-I concentration had no discernible effect on postnatal body growth. We conclude that postnatal body growth is preserved despite complete absence of IGF-I production by the hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359843      PMCID: PMC22065          DOI: 10.1073/pnas.96.12.7088

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants.

Authors:  A Rohlmann; M Gotthardt; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

Review 2.  Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors.

Authors:  C E Stewart; P Rotwein
Journal:  Physiol Rev       Date:  1996-10       Impact factor: 37.312

3.  Preparation of rat liver cells. I. Effect of Ca 2+ on enzymatic dispersion of isolated, perfused liver.

Authors:  P O Seglen
Journal:  Exp Cell Res       Date:  1972-10       Impact factor: 3.905

Review 4.  Insulin-like growth factors and their binding proteins: biological actions.

Authors:  J I Jones; D R Clemmons
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

5.  Inducible gene targeting in mice.

Authors:  R Kühn; F Schwenk; M Aguet; K Rajewsky
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

6.  Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.

Authors:  P F Backeljauw; L E Underwood
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

Review 7.  Growth hormone and bone.

Authors:  C Ohlsson; B A Bengtsson; O G Isaksson; T T Andreassen; M C Slootweg
Journal:  Endocr Rev       Date:  1998-02       Impact factor: 19.871

8.  Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters in hypopituitary dwarf mice.

Authors:  A T Holder; E M Spencer; M A Preece
Journal:  J Endocrinol       Date:  1981-05       Impact factor: 4.286

9.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene.

Authors:  K A Woods; C Camacho-Hübner; M O Savage; A J Clark
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

10.  Growth hormone stimulates longitudinal bone growth directly.

Authors:  O G Isaksson; J O Jansson; I A Gause
Journal:  Science       Date:  1982-06-11       Impact factor: 47.728

View more
  192 in total

1.  Antitumorigenic actions of growth hormone-releasing hormone antagonists.

Authors:  R D Kineman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.

Authors:  Subburaman Mohan; Charmaine Richman; Rongqing Guo; Yousef Amaar; Leah Rea Donahue; Jon Wergedal; David J Baylink
Journal:  Endocrinology       Date:  2003-03       Impact factor: 4.736

Review 3.  Insulin-like growth factor (IGF)-I gene deletion.

Authors:  Cecilia Camacho-Hübner; Katie A Woods; Adrian J L Clark; Martin O Savage
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

4.  Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis.

Authors:  F M Rausa; Y Tan; H Zhou; K W Yoo; D B Stolz; S C Watkins; R R Franks; T G Unterman; R H Costa
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.

Authors:  Chad M Novince; Megan N Michalski; Amy J Koh; Benjamin P Sinder; Payam Entezami; Matthew R Eber; Glenda J Pettway; Thomas J Rosol; Thomas J Wronski; Ken M Kozloff; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

Review 6.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 7.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

8.  Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production.

Authors:  Elisabeth R Barton; SooHyun Park; Jose K James; Catherine A Makarewich; Anastassios Philippou; Davide Eletto; Hanqin Lei; Becky Brisson; Olga Ostrovsky; Zihai Li; Yair Argon
Journal:  FASEB J       Date:  2012-05-30       Impact factor: 5.191

9.  An experimental model of partial insulin-like growth factor-1 deficiency in mice.

Authors:  I Castilla-Cortazar; L Guerra; J E Puche; U Muñoz; R Barhoum; E Escudero; J L Lavandera
Journal:  J Physiol Biochem       Date:  2013-09-18       Impact factor: 4.158

10.  Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver.

Authors:  Charles Cai; Taimur Ahmad; Gloria B Valencia; Jacob V Aranda; Jiliu Xu; Kay D Beharry
Journal:  Growth Horm IGF Res       Date:  2018-03-08       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.